Compare ORIO & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIO | PLSM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | Israel |
| Employees | 188 | 63 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.0M | 22.0M |
| IPO Year | N/A | N/A |
| Metric | ORIO | PLSM |
|---|---|---|
| Price | $0.90 | $4.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 46.7K | 34.4K |
| Earning Date | 03-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $74.52 | N/A |
| Revenue Next Year | $5.07 | N/A |
| P/E Ratio | $4.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $3.00 |
| 52 Week High | $1.40 | $7.15 |
| Indicator | ORIO | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 50.15 |
| Support Level | N/A | $3.73 |
| Resistance Level | $0.98 | $5.00 |
| Average True Range (ATR) | 0.04 | 0.37 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 18.86 | 29.84 |
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.